.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Citi
Chubb
Medtronic
Cerilliant
Queensland Health
US Department of Justice
Mallinckrodt
AstraZeneca
Federal Trade Commission

Generated: July 22, 2017

DrugPatentWatch Database Preview

J And J Consumer Inc Company Profile

« Back to Dashboard

What is the competitive landscape for J AND J CONSUMER INC, and when can generic versions of J AND J CONSUMER INC drugs launch?

J AND J CONSUMER INC has twenty-eight approved drugs.

There are nine US patents protecting J AND J CONSUMER INC drugs.

There are one hundred and eleven patent family members on J AND J CONSUMER INC drugs in forty-three countries.

Summary for Applicant: J And J Consumer Inc

Patents:9
Tradenames:22
Ingredients:10
NDAs:28
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
IMODIUM MULTI-SYMPTOM RELIEF
loperamide hydrochloride; simethicone
TABLET, CHEWABLE;ORAL020606-001Jun 26, 1996DISCNYesNo► Subscribe► Subscribe
J And J Consumer Inc
SINE-AID IB
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL019899-001Dec 31, 1992OTCNoNo► Subscribe► Subscribe
J And J Consumer Inc
IMODIUM A-D
loperamide hydrochloride
SOLUTION;ORAL019487-001Mar 1, 1988OTCYesYes► Subscribe► Subscribe
J And J Consumer Inc
ZYRTEC
cetirizine hydrochloride
SYRUP;ORAL020346-001Sep 27, 1996DISCNNoNo► Subscribe► Subscribe
J And J Consumer Inc
IMODIUM A-D EZ CHEWS
loperamide hydrochloride
TABLET, CHEWABLE;ORAL020448-001Jul 24, 1997DISCNYesNo6,814,978► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for J And J Consumer Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION/DROPS;ORAL020603-001Jun 10, 19965,374,659*PED► Subscribe
J And J Consumer Inc
SUDAFED 24 HOUR
pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020021-002Dec 15, 19924,801,461► Subscribe
J And J Consumer Inc
IMODIUM
loperamide hydrochloride
CAPSULE;ORAL017694-001Approved Prior to Jan 1, 19823,714,159► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET, CHEWABLE;ORAL020801-001Sep 24, 19985,667,794*PED► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020325-001Apr 28, 19955,854,267*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for J AND J CONSUMER INC drugs

Drugname Dosage Strength Tradename Submissiondate
cetirizine hydrochloride
Syrup5 mg/5 mL
ZYRTEC
3/19/2007
cetirizine hydrochloride
Chewable Tablets5 mg and 10 mg
ZYRTEC
3/25/2005
calcium carbonate/ famotadine/ magnesium hydroxide
Chewable Tablets800 mg/ 10 mg/ 165 mg (OTC)
PEPCID COMPLETE
11/1/2004

Non-Orange Book Patents for J And J Consumer Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,060,730Rapidly absorbed liquid compositions► Subscribe
6,489,329 Pharmaceutical compositions for the treatment of rhinitis► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for J And J Consumer Inc Drugs

Country Document Number Estimated Expiration
Estonia05357► Subscribe
Poland206069► Subscribe
United Kingdom9706842► Subscribe
New Zealand501820► Subscribe
China1150900► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for J And J Consumer Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB08/018United Kingdom► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712
/2008Austria► SubscribePRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
C/GB08/005United Kingdom► SubscribeSUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022.
C0004France► SubscribePRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
00125Netherlands► SubscribePRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Teva
US Department of Justice
Novartis
Chubb
Healthtrust
Daiichi Sankyo
Fuji
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot